Tiso et al suggested that ARVD2 associated mutations increase RYR2 mediated calcium release to the cytoplasm where as CPVT associated mutations do not significantly affect cytosolic calcium levels. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.